SunTrust Robinson Humphrey Upgrades Amedisys To Buy

Analysts at SunTrust Robinson Humphrey upgraded

from Neutral to Buy. The price target for Amedisys has been raised from $31.00 to $36.00. Amedisys shares have gained 98.98 percent over the past 52 weeks, while the S&P 500 index has surged 10.18 percent in the same period. Amedisys shares climbed 0.52 percent to close at $29.13 yesterday.